Latest filing published 08 Mar 2013 for Somaxon Pharmaceuticals, Inc..
No signal scores available.
Terrell Cobb discloses dealings in Somaxon Pharmaceuticals, Inc. to SEC (Form 4). We count 24 filings; the first trade dates from 25 September 2006 and the latest from 6 March 2013.
No open-market purchase appears, only 13 sales worth €319k. Besides market trades, the filings include 10 share grants.
The newest entry dates from 8 March 2013: a transaction, in Somaxon Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations